0001951393-24-000002.txt : 20241031 0001951393-24-000002.hdr.sgml : 20241031 20241031141013 ACCESSION NUMBER: 0001951393-24-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20241031 DATE AS OF CHANGE: 20241031 EFFECTIVENESS DATE: 20241031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iCapital ASF IX US Access Fund, L.P. CENTRAL INDEX KEY: 0001951393 ORGANIZATION NAME: IRS NUMBER: 884184298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-462826 FILM NUMBER: 241414555 BUSINESS ADDRESS: STREET 1: C/O COMPLIANCE DEPARTMENT STREET 2: 60 EAST 42ND STREET, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10165 BUSINESS PHONE: (212) 994-7400 MAIL ADDRESS: STREET 1: C/O COMPLIANCE DEPARTMENT STREET 2: 60 EAST 42ND STREET, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10165 D/A 1 primary_doc.xml X0708 D/A LIVE 0001951393 iCapital ASF IX US Access Fund, L.P. C/O COMPLIANCE DEPARTMENT 60 EAST 42ND STREET, 28TH FLOOR NEW YORK NY NEW YORK 10165 (212) 994-7400 DELAWARE None None Limited Partnership true 2022 -- iCapital PE GP, LLC c/o Compliance Department 60 East 42nd Street, 28th Floor New York NY NEW YORK 10165 Promoter General Partner of the Issuer Michael Stanton c/o Compliance Department 60 East 42nd Street, 28th Floor New York NY NEW YORK 10165 Executive Officer Authorized Signatory of the General Partner Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 true 0000897069-23-001504 2023-12-20 true true true false 0 Ardian 121326 None None 1370 Avenue of the Americas, 24th Floor New York NY NEW YORK 10019-4602 All States false Indefinite 72175000 Indefinite false 151 0 0 Certain investors are required to pay (i) an upfront placement fee and/or (ii) an ongoing annual fee to the placement agent. 0 false iCapital ASF IX US Access Fund, L.P. Michael Stanton Michael Stanton Authorized Signatory of the General Partner 2024-10-31